Rapid and accurate identification of isolates of Candida species by melting peak and melting curve analysis of the internally transcribed spacer region 2 fragment (ITS2-MCA).

Rapid identification of clinically important yeasts can facilitate the initiation of anti-fungal therapy, since susceptibility is largely species-dependent. We evaluated melting peak and melting curve analysis of the internally transcribed spacer region 2 fragment (ITS2-MCA) as an identification tool for distinguishing between 16 Candida spp., i.e. Candida albicans, Candida bracarensis, Candida dubliniensis, Candida famata, Candida glabrata, Candida guilliermondii, Candida inconspicua, Candida kefyr, Candida krusei, Candida lipolytica, Candida lusitaniae, Candida nivariensis, Candida norvegensis, Candida parapsilosis, Candida tropicalis and Candida sojae, and Saccharomyces cerevisiae and one species pair, i.e. Candida metapsilosis/Candida orthopsilosis. Starting from a cultured isolate, ITS2-MCA led to differentiation of these species within 6 h. According to our findings, ITS2-MCA offers a simple, rapid and cost-effective method for identification of cultured isolates of the clinically most relevant and prevalent Candida species. Further studies will be necessary to evaluate how it performs on mixed samples and clinical samples.

[1]  B. Nejad,et al.  Prevalence of Candida species in the oral cavity of patients with periodentitis , 2011 .

[2]  D. Fortini,et al.  Rapid, simple, and low-cost identification of Candida species using high-resolution melting analysis. , 2011, Diagnostic microbiology and infectious disease.

[3]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[4]  J. M. Smith.  Evolution of Man , 1962, Nature.

[5]  D. Marriott,et al.  Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  T. Boekhout,et al.  Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities. , 2012, Medical mycology.

[7]  L. Samaranayake,et al.  Prevalence and antifungal drug sensitivity of non-albicans Candida in oral rinse samples of self-caring elderly. , 2011, Gerodontology.

[8]  S. Sanche,et al.  Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System , 1999, Journal of Clinical Microbiology.

[9]  M. Vaneechoutte,et al.  An interlaboratory comparison of ITS2-PCR for the identification of yeasts, using the ABI Prism 310 and CEQ8000 capillary electrophoresis systems , 2005, BMC Microbiology.

[10]  Mark L. Roberts,et al.  129I interlaboratory comparison , 1997 .

[11]  Tasneem Mandviwala,et al.  High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons. , 2010, The Journal of molecular diagnostics : JMD.

[12]  A. Hoerauf,et al.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates , 2009, Journal of Clinical Microbiology.

[13]  S. Lockhart,et al.  Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis , 2008, Journal of Clinical Microbiology.

[14]  M. Vaneechoutte,et al.  Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region , 2002, BMC Microbiology.

[15]  M. Vaneechoutte,et al.  Comparison of VITEK 2 with ITS2-Fragment Length Polymorphism Analysis for Identification of Yeast Species , 2004, Journal of Clinical Microbiology.

[16]  M. Hendrickx,et al.  Screening of strains of the Candida parapsilosis group of the BCCM/IHEM collection by MALDI-TOF MS. , 2011, Diagnostic microbiology and infectious disease.

[17]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .

[18]  H. Levene.  Robust tests for equality of variances , 1961 .

[19]  T. Patterson,et al.  Antifungal resistance in pathogenic fungi. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  D. Snydman,et al.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. , 1996, The American journal of medicine.

[21]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. Brandt,et al.  Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. , 1999, Diagnostic microbiology and infectious disease.

[23]  Z. Khan,et al.  Real-time LightCycler polymerase chain reaction and melting temperature analysis for identification of clinically important Candida spp. , 2009, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[24]  E. Kuijper,et al.  Diagnosis of common dermatophyte infections by a novel multiplex real‐time polymerase chain reaction detection/identification scheme , 2007, The British journal of dermatology.

[25]  A. Velegraki,et al.  Rapid detection of Arthroderma vanbreuseghemii in rabbit skin specimens by PCR-RFLP. , 2006, Veterinary dermatology.

[26]  Petr Hamal,et al.  Performance of optimized McRAPD in identification of 9 yeast species frequently isolated from patient samples: potential for automation , 2009, BMC Microbiology.

[27]  R. J. Kothavade,et al.  Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. , 2010, Journal of medical microbiology.